Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

€10bn battle of the labs as Unilabs and Synlab mull 2020 sales

Europe's largest lab groups could both sell in 2020, with Apax appointing Rothschild to explore a sale of Unilabs while Synlab's majority owner Cinven is also weighing up an exit. The sale values including debt could potentially reach €10bn combined.
November 15, 2019

Exclusive: SpaMedica pulled from sale as UK election and Brexit loom

The largest UK NHS cataract surgery provider, ophthalmic specialist SpaMedica, was pulled from sale recently after just a few weeks on the market and before bids could be submitted, HBI hears. But it could soon be back on the market, and HBI talks to three market experts to find out more about the aborted process, possible prices and suitors.
November 14, 2019

KKR and Triton sell large chunk of Ambea shares

Previous majority shareholders of Ambea KKR and Triton, through their joint investment vehicle Actor SCA, have sold over 12% of Ambea shares to the market this week in their gradual retreat from company ownership. 
November 14, 2019

Exclusive: We name strategic buyer in talks to acquire BMI Healthcare

Independent sources tell HBI that UK hospital chain BMI Healthcare could soon be sold to another hospital operator by its landlord-turned-majority shareholder, just a year after it took over the business. We reveal the likely buyer, give the reaction of advisors and investors, and adjust BMI's likelihood of an imminent sale on HBI Intelligence Deals Pipeline tool to 95%.
November 14, 2019

Merger creates Brazil’s second largest healthcare provider

The merger of lab and imaging specialist Diagnosticos da America (DASA) with São Paulo-based hospital network Rede Impar (RI) will create Brazil's second-largest provider of healthcare services by revenue. A market source tells HBI this could be with a view to an IPO next year.
November 12, 2019

Mehiläinen makes offer for Pihlajalinna and reveals international expansion

As first speculated by HBI last year, Finnish health and social care provider Mehiläinen has offered to buy competitor Pihlajalinna. We talk to Mehiläinen CEO Janne-Olli Järvenpää and local sources about integrating the two companies, competition concerns, the possibility of a bidding war and international expansion, which Järvenpää gives HBI exclusive details on.
November 7, 2019
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us